Seems RHT turned into a lifestyle Company in last 12 months. No r&d updates? No new significant clinical trial signed?And are there any sales and marketing updates? Is the USA market responding to the reimbursed products?Doesn't seem much coming from the reported revenue while significant increase in cash burn in last 4 quarters.
We now have 13 key personnels running the show (as per the company website). Yet can't help but feel disappointed as shareholders (owners) have not had any news of late. Or is it quite simply nothing significant is happening? Has anyone got any idea of Company short term and long term plans or any of the above is not correct ?
Mr Panton, probably it’s time for you to look after yourself and shareholder interest. Maybe it’s time to change board and management, probably bring performers (Just my opinion).
Please do your own research.
RHT Price at posting:
7.0¢ Sentiment: None Disclosure: Not Held
